United Therapeutics (UTHR) Inventory Average (2010 - 2026)

United Therapeutics has disclosed Inventory Average across 17 years of filings, most recently posting $186.0 million for Q2 2026.

• In Q2 2026, Inventory Average rose 11.21% year-over-year to $186.0 million; the TTM figure through Jun 2026 stood at $186.0 million (up 11.21% YoY), while the FY2025 annual figure was $170.5 million, up 26.44% from the prior year.
• Inventory Average came in at $186.0 million for Q2 2026 at United Therapeutics, up from $180.7 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $186.0 million in Q2 2026 to a low of $89.0 million in Q2 2022.
• Average Inventory Average over 5 years is $131.7 million, with a median of $122.2 million recorded in 2024.
• Year-over-year, Inventory Average fell 3.05% in 2022 and surged 40.95% in 2024.
• Over 5 years, Inventory Average stood at $96.5 million in 2022, then grew by 11.97% to $108.0 million in 2023, then surged by 40.95% to $152.3 million in 2024, then increased by 18.06% to $179.8 million in 2025, then gained by 3.48% to $186.0 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $186.0 million in Q2 2026, $180.7 million in Q1 2026, and $179.8 million in Q4 2025.